Gregory Sargen, CFO & EVP, Corp. Dev. at Cambrex, holds 9.61K shares in Avid Bioservices (Ticker: CDMO), holds 31.00K shares in Protara Therapeutics (Ticker: TARA), holds 0.00 shares in Cambrex (Ticker: CBM). Most recently, Gregory Sargen Sold ― shares of Avid Bioservices on Apr 12, 2023 for an estimated value of 141.90K.